Home / Dermatologicals / Pimecrolimus
ATC D11AH02 · Agents for Dermatitis, Excluding Corticosteroids · updated 2 Nov 2026
Pimecrolimus shortage
As of 2 Nov 2026, Pimecrolimus has a reported shortage in 2 of the 16 countries we track (Czechia, Sweden), covering 2 products from 1 company.
Is there a Pimecrolimus shortage?
Yes. As of 2 Nov 2026, Pimecrolimus is reported short in 2 of the 16 countries we track: Czechia, Sweden. The earliest expected return is 28 Dec 2026 (Sweden).
Timeline
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Viatris VTRS · Nasdaq
Compared with similar medicines
ATC group D11AH · Agents for Dermatitis, Excluding CorticosteroidsAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | ELIDEL 10MG/G 10MG/G CRM 15G | VIATRIS HEALTHCARE LIMITED, Dublin | 15 Sep 2026 | 31 Dec 2026 | Manufacturing problem Výrobní důvody |
| SE | Elidel 10 mg/g Tub, 60 g anticipated | Viatris AB | 15 Dec 2026 | 28 Dec 2026 | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there a Pimecrolimus shortage?
Yes. As of 2 Nov 2026, Pimecrolimus is reported short in 2 of the 16 countries we track: Czechia, Sweden. The earliest expected return is 28 Dec 2026 (Sweden).
When will Pimecrolimus be back in stock?
Companies expect supply back from 28 Dec 2026 in Sweden; Czechia: 31 Dec 2026; Sweden: 28 Dec 2026. These are company estimates reported to each authority.
Why is Pimecrolimus in short supply?
The most common reason reported is: manufacturing problem. Reasons by product are listed in the table below.
Which companies have Pimecrolimus shortages?
Viatris.